Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Breast 3Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Prostatic Neoplasms 3Fasting 2

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Angptl4 protein, mouse × Genitourinary × Clear all
NCT05764330 2025-08-06

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Roswell Park Cancer Institute

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT06826924 2025-07-08

7-Days Water-Only Fasting Trial in Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
10 enrolled
Genitourinary

Fasting, Prostatic Neoplasms

NCT02710721 2022-12-13

Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer

Charite University, Berlin, Germany

Phase NA Completed
49 enrolled
Genitourinary

Fasting, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡